N-Acetyltransferase 2 (NAT2) Gene Mutation Analysis
Syphilis, primary
Clostridium difficile (C. Diff) by Molecular Method
RET Proto Oncogene Mutation Analysis
Endometrial Stromal Tumors (EST), 7p15 (JAZF1), 6p21.32 (PHF1), 17p13.3 (YWHAE) Rearrangement, FISH, Tissue
Hepatitis B Surface Antibody, Qualitative
Chromosome Analysis, Solid Tumors
Prosigna Breast Cancer Prognostic Gene Signature
Prostate Specific Antigen (PSA), Total
Maternal Serum Screen, First Trimester

LDS
Sign up
Log in

LDS
/Medical Tests
/Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References

Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
Medical Test

Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.